Last reviewed · How we verify
Risperidone with Clozapine
At a glance
| Generic name | Risperidone with Clozapine |
|---|---|
| Also known as | Risperidone Tablet |
| Sponsor | Shanghai Mental Health Center |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine (PHASE4)
- CLOZAPINE Response in Biotype-1 (PHASE4)
- Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. (PHASE4)
- Magnetic Seizure Therapy for Psychotic Disorders (NA)
- Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT) (PHASE3)
- Study to Compare Clozapine vs Treatment as Usual in People With Intellectual Disability & Treatment-resistant Psychosis (PHASE2)
- Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric Medications (PHASE4)
- A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Risperidone with Clozapine CI brief — competitive landscape report
- Risperidone with Clozapine updates RSS · CI watch RSS
- Shanghai Mental Health Center portfolio CI